Close
Help




JOURNAL

Clinical Medicine Insights: Women's Health

167,216 Journal Article Views | Journal Analytics

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection

Submit a Paper



Publication Date: 13 Feb 2014

Type: Review

Journal: Clinical Medicine Insights: Women's Health

Citation: Clinical Medicine Insights: Women's Health 2014:7 1-8

doi: 10.4137/CMWH.S10353

Abstract

Human Immunodeficiency Virus (HIV) is a retrovirus that can result in rare opportunistic infections occurring in humans. The onset of these infections is known as Acquired Immune Deficiency Syndrome (AIDS). Sexual transmission is responsible for the majority of infections 1, resulting in transmission of HIV due to infected semen or vaginal and cervical secretions containing infected lymphocytes. HIV microbicides are formulations of chemical or biological agents that can be applied to the vagina or rectum with the intention of reducing the acquisition of HIV. Tenofovir is an NRTI that is phosphorylated by adenylate kinase to tenofovir diphosphate, which in turn competes with deoxyadeosine 5’-triphosphate for incorporation into newly synthesized HIV DNA. Once incorporated, tenofovir diphosphate results in chain termination, thus inhibiting viral replication. Tenofovir has been formulated into a range of vaginal formulations, such as rings, tablets gels and films. It has been shown to safe and effective in numerous animal models, while demonstrating safety and acceptability in numerous human trials. The most encouraging results came from the CAPRISA 004 clinical trial which demonstrated that a 1% Tenofovir vaginal gel reduced HIV infection by approximately 39%.



Downloads

PDF  (1.89 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Libertas Academica
testimonial_image
I would like to express my gratitude and say that publishing in LA's journals is one of the best experiences I have had.  I will certainly continue with LA's journals in the future.  the unique feature of this publisher is that it provides a research platform for all young researchers.  Thank you for providing a sustainable publishing environment for us.
Dr Syed Wasif Gillani (Lecturer and Researcher, Discipline of Clinical Pharmacy, USM, Malaysia)
More Testimonials

Quick Links


Follow Us We make it easy to find new research papers.